Pure Global

Saline nasal spray - Vietnam Registration 240000573/PCBA-HN

Access comprehensive regulatory information for Saline nasal spray in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại A medical device is registered under number 240000573/PCBA-HN and manufactured by Song Thanh Pharmaceutical Corporation. The authorized representative in Vietnam is CÔNG TY TNHH DƯỢC PHẨM QUỐC TẾ LIFECARE.

This page provides complete technical specifications, regulatory compliance details, 5 companies making similar products including HẢI LINH Pharmaceutical Co., Ltd, BIBITA Pharmaceutical Technology Co., Ltd., and 5 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
5 Competitors
5 Recent Registrations
240000573/PCBA-HN
Registration Details
Vietnam MOH Registration: 240000573/PCBA-HN
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Saline nasal spray
VN: Dung dịch xịt mũi đẳng trương
Dung dịch xịt mũi đẳng trương
Risk Class TTBYT Loại A

Registration Details

240000573/PCBA-HN

000.00.19.H26-240405-0007

NAZAL Spray

Company Information

CÔNG TY TNHH DƯỢC PHẨM QUỐC TẾ LIFECARE

Technical Details

Nasal cleaning, which helps to remove mucus, dust, allergens (dust, pollen, pollutants, animal hair, etc.) and flu viruses, thus preventing allergic rhinitis and flu. It also helps in the treatment and prevention of various types of nasal congestion, runny nose, rhinitis, allergic rhinitis, sinusitis, etc. It moisturizes and restores the natural moisture of the nasal mucosa, especially during the dry season. It cleans the airways before the use of any medication to optimize the effectiveness of the medication

Dates and Status

Apr 09, 2024